{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:14:24Z","timestamp":1793744064651,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.eururo.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T20:19:15Z","timestamp":1408738755000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis"],"prefix":"10.1016","volume":"67","author":[{"given":"Gail P.","family":"Risbridger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renea A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clouston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Sliwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frydenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Toivanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Papargiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell G.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien M.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.08.007_bib0005","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.08.007_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2014.08.007_bib0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.08.007_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.eururo.2014.08.007_bib0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1940-6207.CAPR-10-0397","article-title":"Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families","volume":"4","author":"Thorne","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.eururo.2014.08.007_bib0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001090050162","article-title":"BRCA2 mutation in Icelandic prostate cancer patients","volume":"75","author":"Sigurdsson","year":"1997","journal-title":"J Mol Med"},{"key":"10.1016\/j.eururo.2014.08.007_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjc.6604453","article-title":"Rapid progression of prostate cancer in men with a BRCA2 mutation","volume":"99","author":"Narod","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2014.08.007_bib0045","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-09-2871","article-title":"Germline BRCA mutations denote a clinicopathologic subset of prostate cancer","volume":"16","author":"Gallagher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2014.08.007_bib0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjc.6605822","article-title":"Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis","volume":"103","author":"Edwards","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2014.08.007_bib0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2014.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2007.11.061","article-title":"Mayo Clinic validation of the D\u2019Amico risk group classification for predicting survival following radical prostatectomy","volume":"179","author":"Boorjian","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0065","doi-asserted-by":"crossref","unstructured":"Bolton D, Cheng Y, Willems-Jones A, et al. Altered significance of D\u2019Amico grading in prostate cancer patients linked to familial breast cancer (kConFab) cohort. Br J Urol Int. In press. http:\/\/dx.doi.org\/10.1111\/bju.12792","DOI":"10.1111\/bju.12792"},{"key":"10.1016\/j.eururo.2014.08.007_bib0070","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pros.22786","article-title":"Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens","volume":"74","author":"Kimura","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2014.08.007_bib0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5694\/j.1326-5377.2000.tb124064.x","article-title":"kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer","volume":"172","author":"Osborne","year":"2000","journal-title":"Med J Austr"},{"key":"10.1016\/j.eururo.2014.08.007_bib0085","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/stem.668","article-title":"Brief report: a bioassay to identify primary human prostate cancer repopulating cells","volume":"29","author":"Toivanen","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.eururo.2014.08.007_bib0090","doi-asserted-by":"crossref","first-page":"187ra71","DOI":"10.1126\/scitranslmed.3005688","article-title":"A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors","volume":"5","author":"Toivanen","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eururo.2014.08.007_bib0095","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nprot.2013.043","article-title":"A preclinical xenograft model of prostate cancer using human tumors","volume":"8","author":"Lawrence","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.eururo.2014.08.007_bib0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B","article-title":"Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression","volume":"43","author":"Cohen","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2014.08.007_bib0105","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.eururo.2012.05.062","article-title":"Do not misinterpret intraductal carcinoma of the prostate as high-grade prostatic intraepithelial neoplasia!","volume":"62","author":"Montironi","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00129039-200209000-00015","article-title":"Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues","volume":"10","author":"Wu","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0120","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"2009"},{"key":"10.1016\/j.eururo.2014.08.007_bib0125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/pros.22579","article-title":"Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?","volume":"73","author":"Bonkhoff","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2014.08.007_bib0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1464-410x.1998.00530.x","article-title":"Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma","volume":"81","author":"Cohen","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.humpath.2010.07.025","article-title":"Ductal adenocarcinoma of the prostate","volume":"42","author":"Cohen","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0140","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/1097-0142(19861015)58:8<1714::AID-CNCR2820580823>3.0.CO;2-M","article-title":"Cribriform adenocarcinoma of the prostate","volume":"58","author":"McNeal","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.08.007_bib0145","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00000478-199807000-00006","article-title":"Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications","volume":"22","author":"Rubin","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2014.08.007_bib0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/his.12198","article-title":"Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study","volume":"63","author":"Watts","year":"2013","journal-title":"Histopathology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814007490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814007490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T20:38:19Z","timestamp":1717274299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814007490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0302283814007490"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.007","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}